A food supplement targeting gut bacteria in ulcerative colitis

This trial is testing a microbiome-targeted food supplement designed to help restore healthy bacteria in your gut and reduce inflammation from ulcerative colitis. The medication works by promoting the growth of beneficial bacteria that produce short-chain fatty acids, which help calm intestinal inflammation. This treatment offers a non-immunosuppressive option for people whose symptoms persist despite standard therapy.

Many people with ulcerative colitis continue to have symptoms and inflammation even when taking standard medications like mesalamine, and some want to avoid stronger immunosuppressive drugs. Research shows that people with active ulcerative colitis have unhealthy gut bacteria with fewer beneficial species, so this medication aims to restore that balance and reduce inflammation naturally.